Gale E. Smith

Person

Darnestown, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for treating respiratory disease
- Patent number 12,083,228
- Issue date Sep 10, 2024
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for inducing immune responses against Clos...
- Patent number 11,938,179
- Issue date Mar 26, 2024
- Novavax, Inc.
- Jing-Hui Tian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent influenza nanoparticle vaccines
- Patent number 11,896,662
- Issue date Feb 13, 2024
- Novavax, Inc.
- Sarathi Boddapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Corona virus vaccine formulations
- Patent number 11,896,664
- Issue date Feb 13, 2024
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 11,541,112
- Issue date Jan 3, 2023
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,446,374
- Issue date Sep 20, 2022
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 11,364,294
- Issue date Jun 21, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent influenza nanoparticle vaccines
- Patent number 11,278,612
- Issue date Mar 22, 2022
- Novavax, Inc.
- Sarathi Boddapati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 11,253,585
- Issue date Feb 22, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 11,253,586
- Issue date Feb 22, 2022
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inducing immune responses against Clos...
- Patent number 11,123,419
- Issue date Sep 21, 2021
- Novavax, Inc.
- Jing-Hui Tian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 11,052,146
- Issue date Jul 6, 2021
- Novavax, Inc.
- Peter M. Pushko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine formulations
- Patent number 10,953,089
- Issue date Mar 23, 2021
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV)...
- Patent number 10,751,410
- Issue date Aug 25, 2020
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,729,760
- Issue date Aug 4, 2020
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 10,548,968
- Issue date Feb 4, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 10,544,399
- Issue date Jan 28, 2020
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccine compositions having improved stability and immunogenicity
- Patent number 10,426,829
- Issue date Oct 1, 2019
- Novavax, Inc.
- Gale Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 10,188,723
- Issue date Jan 29, 2019
- Novavax, Inc.
- Gale Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Rabies glycoprotein virus-like particles (VLPS)
- Patent number 10,086,065
- Issue date Oct 2, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 10,022,437
- Issue date Jul 17, 2018
- Novavax, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 9,951,317
- Issue date Apr 24, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,937,253
- Issue date Apr 10, 2018
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,731,000
- Issue date Aug 15, 2017
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rabies glycoprotein virus-like particles (VLPS)
- Patent number 9,724,405
- Issue date Aug 8, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,717,786
- Issue date Aug 1, 2017
- Novavax, Inc.
- Peter M. Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus like particles (VLPs)
- Patent number 9,694,066
- Issue date Jul 4, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified RSV F proteins and methods of their use
- Patent number 9,675,685
- Issue date Jun 13, 2017
- Novavax, Inc.
- Peter Pushko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functional influenza virus-like particles (VLPS)
- Patent number 9,623,104
- Issue date Apr 18, 2017
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Highly efficient influenza matrix (M1) proteins
- Patent number 9,464,276
- Issue date Oct 11, 2016
- Novavax, Inc.
- Gale Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
- Publication number 20240423926
- Publication date Dec 26, 2024
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SARS-COV-2 VACCINE COMPOSITIONS
- Publication number 20240374712
- Publication date Nov 14, 2024
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
- Publication number 20240325523
- Publication date Oct 3, 2024
- NOVAVAX, INC.
- Nita PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
- Publication number 20240293530
- Publication date Sep 5, 2024
- NOVAVAX, INC.
- Sarathi BODDAPATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20240165221
- Publication date May 23, 2024
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20230330216
- Publication date Oct 19, 2023
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20230293667
- Publication date Sep 21, 2023
- NOVAVAX, INC.
- Peter M. PUSHKO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20230070886
- Publication date Mar 9, 2023
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
- Publication number 20220387579
- Publication date Dec 8, 2022
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM
- Publication number 20220354944
- Publication date Nov 10, 2022
- NOVAVAX, INC.
- Nita PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20220332765
- Publication date Oct 20, 2022
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...
- Publication number 20220211834
- Publication date Jul 7, 2022
- NOVAVAX, INC.
- Jing-Hui TIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20220125914
- Publication date Apr 28, 2022
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
- Publication number 20220080039
- Publication date Mar 17, 2022
- NOVAVAX, INC.
- Sarathi BODDAPATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20210228708
- Publication date Jul 29, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE FORMULATIONS
- Publication number 20210228709
- Publication date Jul 29, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
- Publication number 20210137845
- Publication date May 13, 2021
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
- Publication number 20200101151
- Publication date Apr 2, 2020
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...
- Publication number 20200085934
- Publication date Mar 19, 2020
- NOVAVAX, INC.
- Jing-Hui TIAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20200030436
- Publication date Jan 30, 2020
- NOVAVAX, INC.
- Peter M. PUSHKO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20190314484
- Publication date Oct 17, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTIVALENT INFLUENZA NANOPARTICLE VACCINES
- Publication number 20190314487
- Publication date Oct 17, 2019
- NOVAVAX, INC.
- Sarathi BODDAPATI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20190224307
- Publication date Jul 25, 2019
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
- Publication number 20190134187
- Publication date May 9, 2019
- NOVAVAX, INC.
- Peter M. PUSHKO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
- Publication number 20190062713
- Publication date Feb 28, 2019
- NOVAVAX, INC.
- Gale SMITH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20190038738
- Publication date Feb 7, 2019
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY
- Publication number 20180133308
- Publication date May 17, 2018
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)
- Publication number 20180110851
- Publication date Apr 26, 2018
- NOVAVAX, INC.
- Gale SMITH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)
- Publication number 20180021428
- Publication date Jan 25, 2018
- NOVAVAX, INC.
- Gale SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE COMPOSITIONS CONTAINING MODIFIED ZIKA VIRUS ANTIGENS
- Publication number 20170354729
- Publication date Dec 14, 2017
- NOVAVAX, INC.
- Ye LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Gale E. Smith

Person

Patents Grantslast 30 patents

Methods and compositions for treating respiratory disease

Methods and compositions for inducing immune responses against Clos...

Multivalent influenza nanoparticle vaccines

Corona virus vaccine formulations

Coronavirus vaccine formulations

Modified RSV F proteins and methods of their use

Vaccine compositions having improved stability and immunogenicity

Multivalent influenza nanoparticle vaccines

Vaccine compositions having improved stability and immunogenicity

Coronavirus vaccine formulations

Methods and compositions for inducing immune responses against Clos...

Modified RSV F proteins and methods of their use

Coronavirus vaccine formulations

Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV)...

Functional influenza virus like particles (VLPs)

Functional influenza virus-like particles (VLPS)

Highly efficient influenza matrix (M1) proteins

Vaccine compositions having improved stability and immunogenicity

Functional influenza virus like particles (VLPs)

Rabies glycoprotein virus-like particles (VLPS)

Modified RSV F proteins and methods of their use

Highly efficient influenza matrix (M1) proteins

Functional influenza virus-like particles (VLPS)

Modified RSV F proteins and methods of their use

Rabies glycoprotein virus-like particles (VLPS)

Modified RSV F proteins and methods of their use

Functional influenza virus like particles (VLPs)

Modified RSV F proteins and methods of their use

Functional influenza virus-like particles (VLPS)

Highly efficient influenza matrix (M1) proteins

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE

SARS-COV-2 VACCINE COMPOSITIONS

CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

CORONAVIRUS VACCINE FORMULATIONS

CORONAVIRUS VACCINE FORMULATIONS

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

CORONAVIRUS VACCINE FORMULATIONS

VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY

CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM

CORONAVIRUS VACCINE FORMULATIONS

METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...

CORONAVIRUS VACCINE FORMULATIONS

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

CORONAVIRUS VACCINE FORMULATIONS

CORONAVIRUS VACCINE FORMULATIONS

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE

VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY

METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOS...

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

MULTIVALENT INFLUENZA NANOPARTICLE VACCINES

RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)

MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE

HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS

FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY

FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs)

RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS)

VACCINE COMPOSITIONS CONTAINING MODIFIED ZIKA VIRUS ANTIGENS